MedPath

To study the effect of TILAKUSUMADILEPA in skin disease

Phase 2
Not yet recruiting
Conditions
Other disorders of skin and subcutaneous tissue in diseases classified elsewhere. Ayurveda Condition: VIPADIKA,
Registration Number
CTRI/2022/01/039662
Lead Sponsor
Ayurved Seva Sangh Ayurved Mahavidyalaya Nashik
Brief Summary

The diagnosed patients of  Vipadika will be treated for group A with  Tilakusumadilepa mentioned in Bhaishajya Ratnawali 125 gms for 30 days used  twice a day as topical application.The comparative drug for group B with Vipadikahar lepa mentioned in Sahastrayog will be given 125 gms for 30 days used twice a day as topical application.Assessement criteria will be those patients with classical signs and symptoms of vipadika -panipadsphutan  vedana, Kandu, Khara sparshata,strava.Patients with other skin diseases Like Ringworm, scabies,Eczema etc will be excluded from study.The patients will be selected from kayachikitsa opd no 13..

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
70
Inclusion Criteria
  • Patients with classical signs and symptoms of vipadika.
  • panipadsphutan, vedana Kandu Kharasparshata Strava Patients of Age group.
  • 60 years of Age. Patients willing to participate in the study , who give written consent.
Exclusion Criteria
  • Patients below 18 & above 60 years of age.
  • Patients with other uncontrolled systemic disorders like DM/ HTN/Cardiac disorders/leprosy/Tuberculosis/Malignancy will be excluded.
  • Patients with other skin diseases Like Ringworm, scabies, Eczema etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
REDUCTION IN SIGN AND SYMPTOMS OF VIPADIKA30 days
Secondary Outcome Measures
NameTimeMethod
COST EFFECTIVE TREATMENT30 DAYS

Trial Locations

Locations (1)

OPD no 13 kayachikitsa Ayurved Seva Sangha;s Ayurved Mahavidyalaya Panchwati Nashik.

🇮🇳

Nashik, MAHARASHTRA, India

OPD no 13 kayachikitsa Ayurved Seva Sangha;s Ayurved Mahavidyalaya Panchwati Nashik.
🇮🇳Nashik, MAHARASHTRA, India
Shamala Sammaiah Elkapelli
Principal investigator
8999145793
shamlaelkapelli926@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.